10x Genomics sees robust growth across platforms in Q4 2023
Macroeconomic uncertainties could impact spending in academia and biopharma.
NiSource targets $19.4B CapEx plan with 6%-8% EPS growth through 2029
President and CEO Lloyd Yates highlighted NiSource's $19.4 billion base CapEx plan for 2025-2029, which is expected to drive 8%-10% rate base growth and support 6%-8% annual adjusted EPS growth. The ...